After more than 5 years of hard work, we are thrilled to announce that the DePPaRT study is now complete! Our core team (with invaluable help from site coordinators and waveform adjudicators) has worked hard to review and finalize data, and we have completed the main study analysis. Along the way we have continued to publish papers, engage new colleagues, and build collaborations all over the world.
Although the DePPaRT data collection and main study analysis have been finalized, there remains much to do. Some ongoing exciting projects include:
In addition to this scientific work, our team is actively engaging with stakeholders and policy-makers as part of a knowledge translation strategy to ensure that our results are appropriately disseminated. A notable part of this initiative includes integration with Canadian Blood Services' initiative to harmonize criteria for death determination. Check back soon for updates and links to other knowledge translation activities!
Although the DePPaRT data collection and main study analysis have been finalized, there remains much to do. Some ongoing exciting projects include:
- analysis of secondary study outcomes, including a paper on waveform variability led by Nathan Scales and a prediction of time to death study led by Jason Shahin
- analysis of Qualitative Study outcomes, led by Jennifer Chandler
- secondary analysis of DePPaRT data focused on processes of withdrawal of life sustaining therapies, funded as part of a CDTRP Astellas Research Innovation Grant
- analysis of international data
In addition to this scientific work, our team is actively engaging with stakeholders and policy-makers as part of a knowledge translation strategy to ensure that our results are appropriately disseminated. A notable part of this initiative includes integration with Canadian Blood Services' initiative to harmonize criteria for death determination. Check back soon for updates and links to other knowledge translation activities!
RSS Feed
